Creative Bioarray Releases a Wide Range of iPSC Differentiation Kits to Support IPS Cell Differentiation

January 31 20:29 2023
Creative Bioarray announced the release of its wide range of iPSC differentiation kits to support iPS cell differentiation.

New York, USA – January 31, 2023 – Creative Bioarray, one of the world’s leading biotechnology products and services providers, is dedicated to becoming a profitable premier provider of quality life science research reagents and services helping customers develop innovative methods and products. Creative Bioarray is widely recognized as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. With unique clinical-grade products for stem cell and cell therapy applications, Creative Bioarray announced the release of its wide range of iPSC differentiation kits to support iPS cell differentiation.

Compared to immortalized cell lines and primary mouse neurons, human induced pluripotent stem cells (iPSCs) offer a more physiologically relevant method for studying neuronal activity in vitro. However, differentiating stem cells into the desired cell type is a time-consuming and labor-intensive process. Creative Bioarray offers a solution that includes a range of easy-to-use differentiation kits and maintenance media, as well as a range of human iPSC-derived excitatory, GABAergic, and cholinergic neurons. These products are designed to accelerate stem cell research without sacrificing cell purity.

Obtain highly pure populations of excitatory neurons from iPSCs using iPSC-derived excitatory neurons, this easy-to-use kit generates differentiated cells without leaving a genetic footprint, Creative Bioarray also offers a series of iPSC-derived excitatory neurons. Creative Bioarray’s stem cell differentiation service produces highly pure differentiated or terminally differentiated cells in one week. Creative Bioarray provides stem cell differentiation services with the fastest turnaround time, and the differentiation process produces homogenous cell cultures with no genetic footprint.

Due to the lack of suitable human cell lines and/or the inability to obtain primary cells from humans, researchers have traditionally used non-human cells, such as mouse cells, for basic, translational and applied research. But the advent of human iPS cells has changed that, because these pluripotent cells can differentiate into essentially any type of cell in the body. With the Quick-Tissue™ family of kits, human iPSC-derived cells can be generated quickly and easily in any laboratory, opening the door to physiologically relevant models of human biology and disease.

“Creative Bioarray’s cells and kits accelerate these studies through our rapid, consistent, and efficient differentiation of patient-specific iPS cells into desired cell types.” said Hannah Cole, the marketing director of Creative Bioarray, she also added, “Our team is dedicated to providing high-quality products, service and customer support. Our iPSC differentiation technology can be used in any laboratory.”

About Creative Bioarray

Creative Bioarray is dedicated to offering customers innovative biotechnology products and services for research use to greatly enhance and drive innovation and standards in science. As a well-recognized industry leader with more than 10 years of experience and in-house expert support, Creative Bioarray has already countenanced research all around the world.

Media Contact
Company Name: Creative Bioarray
Contact Person: Hannah Cole
Email: Send Email
Phone: 1-631-386-8241
Country: United States